DS
CGEM icon

David Shaw’s Cullinan Oncology CGEM Stock Holding History

David Shaw’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,365
Closed -$149K – 4597
2025
Q4 		$149K Sell
14,365
-11,254
-44% -$102K ﹤0.01% 4371
2025
Q3 		$152K Buy
25,619
+290
+1% +$2.12K ﹤0.01% 4318
2025
Q2 		$191K Sell
25,329
-6,165
-20% -$49.5K ﹤0.01% 4063
2025
Q1 		$238K Sell
31,494
-17,438
-36% -$167K ﹤0.01% 3857
2024
Q4 		$596K Sell
48,932
-10,308
-17% -$148K ﹤0.01% 3510
2024
Q3 		$992K Sell
59,240
-153,208
-72% -$2.72M ﹤0.01% 3277
2024
Q2 		$3.71M Buy
212,448
+150,827
+245% +$3.21M ﹤0.01% 2087
2024
Q1 		$1.05M Buy
61,621
+12,702
+26% +$196K ﹤0.01% 3064
2023
Q4 		$498K Buy
48,919
+9,217
+23% +$81.7K ﹤0.01% 3514
2023
Q3 		$359K Sell
39,702
-16,243
-29% -$169K ﹤0.01% 3544
2023
Q2 		$602K Sell
55,945
-17,627
-24% -$187K ﹤0.01% 3345
2023
Q1 		$753K Sell
73,572
-26,129
-26% -$288K ﹤0.01% 3345
2022
Q4 		$1.05M Buy
99,701
+22,261
+29% +$270K ﹤0.01% 3411
2022
Q3 		$993K Sell
77,440
-17,546
-18% -$236K ﹤0.01% 3600
2022
Q2 		$1.22M Buy
+94,986
New +$1.08M ﹤0.01% 3494
2021
Q3 		– Sell
-60,319
Closed -$1.55M – 4984
2021
Q2 		$1.55M Sell
60,319
-3,714
-6% -$114K ﹤0.01% 3180
2021
Q1 		$2.67M Buy
+64,033
New +$2.6M ﹤0.01% 2342

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

David Shaw's CGEM Position: Q1 2026 in Review

David Shaw sold out of Cullinan Oncology (CGEM) in Q1 2026, closing a stake of 14,365 shares — an estimated $149K sold.

David Shaw first reported a position in CGEM in Q1 2021 and held it in 17 quarters. The position peaked at $3.71M in Q2 2024. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • David Shaw reported no remaining Cullinan Oncology position as of Q1 2026 after selling out during the quarter.
  • David Shaw sold 14,365 Cullinan Oncology shares in Q1 2026, an estimated $149K.
  • David Shaw first reported a position in Cullinan Oncology in Q1 2021 and held it in 17 quarters.
  • David Shaw's Cullinan Oncology position peaked at $3.71M in Q2 2024.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.